Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.5.1 (
succinate dehydrogenase
)
8,177
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of anilazine on growth, respiration and enzyme activity of E. coli has been studied.
Anilazine
delays the growth of E. coli by prolonging the lag period. It inhibits glucose oxidation by 60% and succinate oxidation by 100%. It also inhibits in vitro
succinic dehydrogenase
activity. It seems that the inhibition of E. coli by anilazine is because of inhibition of respiratory enzymes.
...
PMID:Effect of anilazine on growth, respiration and enzyme activity of Escherichia coli. 703 97